Vanguard Portfolio Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$460M Sell
6,348,862
-157,498
-2% -$11.3M 0.02% 706
2026
Q2
$460M Buy
6,506,360
+26,023
+0.4% +$1.41M 0.02% 751
2026
Q1
$339M Buy
+6,480,337
New +$389M 0.02% 828

Other funds holding TECH

Vanguard Portfolio Management's TECH Position: Q3 2026 in Review

Vanguard Portfolio Management reduced its Bio-Techne (TECH) stake by 2.4% in Q3 2026, selling an estimated $11.3M and leaving 6,348,862 shares worth $460M. The position accounts for 0.02% of the portfolio, ranked #706.

Vanguard Portfolio Management first reported a position in TECH in Q1 2026 and has held it in 3 quarters since. 582 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • Vanguard Portfolio Management held 6,348,862 shares of Bio-Techne worth $460M as of Q3 2026.
  • Vanguard Portfolio Management sold 157,498 Bio-Techne shares in Q3 2026, an estimated $11.3M.
  • Bio-Techne made up 0.02% of Vanguard Portfolio Management's portfolio in Q3 2026, its #706 holding.
  • Vanguard Portfolio Management first reported a position in Bio-Techne in Q1 2026 and has held it in 3 quarters since.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.